Bortezomib is a potent 20S proteasome inhibitor with Ki of 0.6 nM. It exhibits favorable selectivity towards tumor cells over normal cells. Bortezomib (PS-341) inhibits NF-κB and induces ERK phosphorylation to suppress cathepsin B and inhibit the catalytic process of autophagy in ovarian cancer and other solid tumors.
Tags: buy Bortezomib | purchase Bortezomib | Bortezomib cost | order Bortezomib | Bortezomib chemical structure | Bortezomib in vivo | Bortezomib in vitro | Bortezomib formula | Bortezomib molecular weight